452 related articles for article (PubMed ID: 31831187)
1. Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.
Kaide CG; Gulseth MP
J Emerg Med; 2020 Feb; 58(2):217-233. PubMed ID: 31831187
[TBL] [Abstract][Full Text] [Related]
2. Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols.
Huisman MV; Fanikos J
Am J Med; 2016 Nov; 129(11S):S89-S96. PubMed ID: 27569673
[TBL] [Abstract][Full Text] [Related]
3. Reversal of Newer Direct Oral Anticoagulant Drugs (DOACs).
Hussain SS; Tyroch AH; Mukherjee D
Cardiovasc Hematol Agents Med Chem; 2017; 14(2):76-81. PubMed ID: 27215215
[TBL] [Abstract][Full Text] [Related]
4. How can we reverse bleeding in patients on direct oral anticoagulants?
Crowther M; Cuker A
Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
[TBL] [Abstract][Full Text] [Related]
5. Idarucizumab and factor Xa reversal agents: role in hospital guidelines and protocols.
Huisman MV; Fanikos J
Am J Emerg Med; 2016 Nov; 34(11S):46-51. PubMed ID: 27697438
[TBL] [Abstract][Full Text] [Related]
6. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures.
Levy JH
Am J Med; 2016 Nov; 129(11S):S47-S53. PubMed ID: 27569675
[TBL] [Abstract][Full Text] [Related]
7. Reversal agents for use with direct and indirect anticoagulants.
Smythe MA; Trujillo T; Fanikos J
Am J Health Syst Pharm; 2016 May; 73(10 Suppl 2):S27-48. PubMed ID: 27147456
[TBL] [Abstract][Full Text] [Related]
8. Reversal of direct oral anticoagulants.
Almegren M
Vasc Health Risk Manag; 2017; 13():287-292. PubMed ID: 28769570
[TBL] [Abstract][Full Text] [Related]
9. Reversal agents for non-vitamin K antagonist oral anticoagulants.
Levy JH; Douketis J; Weitz JI
Nat Rev Cardiol; 2018 May; 15(5):273-281. PubMed ID: 29345686
[TBL] [Abstract][Full Text] [Related]
10. Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal Agents.
Ruff CT; Giugliano RP; Antman EM
Circulation; 2016 Jul; 134(3):248-61. PubMed ID: 27436881
[TBL] [Abstract][Full Text] [Related]
11. Discontinuation and management of direct-acting anticoagulants for emergency procedures.
Levy JH
Am J Emerg Med; 2016 Nov; 34(11S):14-18. PubMed ID: 27697442
[TBL] [Abstract][Full Text] [Related]
12. Antidotes for reversal of direct oral anticoagulants.
Dobesh PP; Bhatt SH; Trujillo TC; Glaubius K
Pharmacol Ther; 2019 Dec; 204():107405. PubMed ID: 31521696
[TBL] [Abstract][Full Text] [Related]
13. Reversal agents for direct oral anticoagulants: considerations for hospital physicians and intensivists.
Desai NR; Cornutt D
Hosp Pract (1995); 2019 Aug; 47(3):113-122. PubMed ID: 31317796
[TBL] [Abstract][Full Text] [Related]
14. Reversing the Effect of Oral Anticoagulant Drugs: Established and Newer Options.
Ansell JE
Am J Cardiovasc Drugs; 2016 Jun; 16(3):163-70. PubMed ID: 26872887
[TBL] [Abstract][Full Text] [Related]
15. Preclinical and clinical data for factor Xa and "universal" reversal agents.
Milling TJ; Kaatz S
Am J Emerg Med; 2016 Nov; 34(11S):39-45. PubMed ID: 27697443
[TBL] [Abstract][Full Text] [Related]
16. [State of the art: Direct oral anticoagulants and transfusion].
Martin AC; Godier A; Smadja DM; Mauge L; Fischer AM
Transfus Clin Biol; 2017 Sep; 24(3):154-159. PubMed ID: 28673500
[TBL] [Abstract][Full Text] [Related]
17. A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA).
Rogers KC; Finks SW
Am J Med; 2019 Jan; 132(1):38-41. PubMed ID: 30053385
[TBL] [Abstract][Full Text] [Related]
18. Monitoring and reversal of direct oral anticoagulants.
Cuker A; Siegal D
Hematology Am Soc Hematol Educ Program; 2015; 2015():117-24. PubMed ID: 26637710
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
Milling TJ; Kaatz S
Am J Med; 2016 Nov; 129(11S):S80-S88. PubMed ID: 27575436
[TBL] [Abstract][Full Text] [Related]
20. Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data.
Tummala R; Kavtaradze A; Gupta A; Ghosh RK
Int J Cardiol; 2016 Jul; 214():292-8. PubMed ID: 27082776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
